144 related articles for article (PubMed ID: 36216763)
1. Papillary renal cell neoplasm with reverse polarity: A new subtype of renal tumour with favorable prognosis.
Conde-Ferreirós M; Domínguez-de Dios J; Juaneda-Magdalena L; Bellas-Pereira A; San Miguel Fraile MP; Peteiro Cancelo MÁ; Gómez-de María C; Álvarez Sarria M; Betancor Santos MÁ; González-Carreró J; Ortiz-Rey JA
Actas Urol Esp (Engl Ed); 2022 Dec; 46(10):600-605. PubMed ID: 36216763
[TBL] [Abstract][Full Text] [Related]
2. Papillary renal neoplasm with reverse polarity with a favorable prognosis should be separated from papillary renal cell carcinoma.
Liu Y; Zhang H; Li X; Wang S; Zhang Y; Zhang X; Xu T; Dong Y; Dong L; Zhou L; Yang X; Wang C
Hum Pathol; 2022 Sep; 127():78-85. PubMed ID: 35724772
[TBL] [Abstract][Full Text] [Related]
3. Papillary renal neoplasm with reverse polarity: an observational study of histology, immunophenotypes, and molecular variation.
Han H; Yin SY; Song RX; Zhao J; Yu YW; He MX; Wang H
Transl Androl Urol; 2024 Mar; 13(3):383-396. PubMed ID: 38590969
[TBL] [Abstract][Full Text] [Related]
4. Papillary renal neoplasm with reverse polarity: a clinicopathologic study of 43 cases with a focus on the expression of KRAS signaling pathway downstream effectors.
Kim B; Lee S; Moon KC
Hum Pathol; 2023 Dec; 142():1-6. PubMed ID: 37797754
[TBL] [Abstract][Full Text] [Related]
5. Recurrent KRAS mutations identified in papillary renal neoplasm with reverse polarity-a comparative study with papillary renal cell carcinoma.
Kim SS; Cho YM; Kim GH; Kee KH; Kim HS; Kim KM; Kim JH; Choi C
Mod Pathol; 2020 Apr; 33(4):690-699. PubMed ID: 31953522
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological and molecular characterisation of papillary renal neoplasm with reverse polarity and its renal papillary adenoma analogue.
Chang HY; Hang JF; Wu CY; Lin TP; Chung HJ; Chang YH; Pan CC
Histopathology; 2021 Jun; 78(7):1019-1031. PubMed ID: 33351968
[TBL] [Abstract][Full Text] [Related]
7. Papillary renal neoplasm with reverse polarity-a comparative study with CCPRCC, OPRCC, and PRCC1.
Wang T; Ding X; Huang X; Ye J; Li H; Cao S; Gao Y; Ma X; Huang Q; Wang B
Hum Pathol; 2022 Nov; 129():60-70. PubMed ID: 35977593
[TBL] [Abstract][Full Text] [Related]
8. [Papillary renal neoplasm with reverse polarity: a clinicopathological analysis].
Ji RH; Wang XT; Li R; Ye SB; Wang X; Ma HH; Lu ZF; Rao Q; Xia QY
Zhonghua Bing Li Xue Za Zhi; 2022 Jan; 51(1):23-27. PubMed ID: 34979749
[No Abstract] [Full Text] [Related]
9. Papillary renal neoplasm with reverse polarity: A clinicopathological and molecular genetic characterization of 16 cases with expanding the morphologic spectrum and further support for a novel entity.
Shen M; Yin X; Bai Y; Zhang H; Ru G; He X; Teng X; Chen G; Zhao M
Front Oncol; 2022; 12():930296. PubMed ID: 35936734
[TBL] [Abstract][Full Text] [Related]
10. Papillary Renal Neoplasm With Reverse Polarity: A Clinical, Pathologic, and Molecular Study of 8 Renal Tumors From a Single Institution.
Nova-Camacho LM; Martin-Arruti M; Díaz IR; Panizo-Santos Á
Arch Pathol Lab Med; 2023 Jun; 147(6):692-700. PubMed ID: 36170616
[TBL] [Abstract][Full Text] [Related]
11. Ipsilateral synchronous papillary renal neoplasm with reverse polarity and urothelial carcinoma in a renal transplant recipient: a rare case report with molecular analysis and literature review.
Li D; Liu F; Chen Y; Li P; Liu Y; Pang Y
Diagn Pathol; 2023 Nov; 18(1):120. PubMed ID: 37924117
[TBL] [Abstract][Full Text] [Related]
12. Morphological, immunohistochemical, and genomic analyses of papillary renal neoplasm with reverse polarity.
Kiyozawa D; Kohashi K; Takamatsu D; Yamamoto T; Eto M; Iwasaki T; Motoshita J; Shimokama T; Kinjo M; Oshiro Y; Yonemasu H; Oda Y
Hum Pathol; 2021 Jun; 112():48-58. PubMed ID: 33811832
[TBL] [Abstract][Full Text] [Related]
13. Papillary renal neoplasm with reverse polarity with a favorable prognosis: Two cases report and literature review.
Yuzhi Z; Zhen L; Yu X; Boju P; Weigang Y; Xingcheng W
Front Oncol; 2022; 12():1011422. PubMed ID: 36387104
[TBL] [Abstract][Full Text] [Related]
14. Papillary Renal Neoplasm With Reverse Polarity Is Often Cystic: Report of 7 Cases and Review of 93 Cases in the Literature.
Wei S; Kutikov A; Patchefsky AS; Flieder DB; Talarchek JN; Al-Saleem T; Dulaimi E; Uzzo RG; Testa JR; Pei J
Am J Surg Pathol; 2022 Mar; 46(3):336-343. PubMed ID: 34352808
[TBL] [Abstract][Full Text] [Related]
15. Frequent KRAS mutations in oncocytic papillary renal neoplasm with inverted nuclei.
Tong K; Zhu W; Fu H; Cao F; Wang S; Zhou W; Liu C; Chen D; Fan S; Hu Z
Histopathology; 2020 Jun; 76(7):1070-1083. PubMed ID: 31997427
[TBL] [Abstract][Full Text] [Related]
16. Non-coding RNA and gene expression analyses of papillary renal neoplasm with reverse polarity (PRNRP) reveal distinct pathological mechanisms from other renal neoplasms.
Nemours S; Armesto M; Arestín M; Manini C; Giustetto D; Sperga M; Pivovarcikova K; Pérez-Montiel D; Hes O; Michal M; López JI; Lawrie CH
Pathology; 2024 Jun; 56(4):493-503. PubMed ID: 38413252
[TBL] [Abstract][Full Text] [Related]
17. Rare papillary renal neoplasm with reverse polarity: A case report and review of the literature.
Tu X; Zhuang X; Chen Q; Wang W; Huang C
Front Oncol; 2023; 13():1101268. PubMed ID: 37007143
[TBL] [Abstract][Full Text] [Related]
18. Papillary renal neoplasm with reverse polarity is biologically and clinically distinct from eosinophilic papillary renal cell carcinoma.
Castillo VF; Trpkov K; Van der Kwast T; Rotondo F; Hamdani M; Saleeb R
Pathol Int; 2024 Apr; 74(4):222-226. PubMed ID: 38456605
[TBL] [Abstract][Full Text] [Related]
19. Recurrent KRAS mutations are early events in the development of papillary renal neoplasm with reverse polarity.
Al-Obaidy KI; Saleeb RM; Trpkov K; Williamson SR; Sangoi AR; Nassiri M; Hes O; Montironi R; Cimadamore A; Acosta AM; Alruwaii ZI; Alkashash A; Hassan O; Gupta N; Osunkoya AO; Sen JD; Baldrige LA; Sakr WA; Idrees MT; Eble JN; Grignon DJ; Cheng L
Mod Pathol; 2022 Sep; 35(9):1279-1286. PubMed ID: 35152262
[TBL] [Abstract][Full Text] [Related]
20. Papillary renal neoplasm with reverse polarity may be a novel renal cell tumor entity with low malignant potential.
Yang T; Kang E; Zhang L; Zhuang J; Li Y; Jiang Y; Wang H; Yu W; Zhang W
Diagn Pathol; 2022 Aug; 17(1):66. PubMed ID: 36002896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
